Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Bullboard Posts
Comment by techfan49on Oct 21, 2018 11:40am
188 Views
Post# 28843196

RE:This was a news report

RE:This was a news report Net cash balance should grow while eps grows. That's where fiscal planning comes in. Cross your toes. Congrats to those who bought in at .07 to .15 Additional detective needs to be done. Remember that right now the entire industry is being reshuffled by banks...stocks that were at a bubble inflated price will return to earth as banks load up on shares of.companies that generate profits now as in positive growing eps. The banks will be gazing into the 6 month to 18 month window. Which larger capped companies will encounter speed bumps. Most funds unless classified as speculative , will not include penny stocks in their funds. Only the cowboy finds do. I think that this is a stock to add on dips and hold as it can become a 10 bagger. How the team manages the company will determine how quickly people add or sell
Bullboard Posts